Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins
Background: There are some reports about the antitumor effects of statins in these days. Statins decrease the level of cholesterol in the blood by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Inhibition of this enzyme decreases intracellular cholesterol synthesis. Thus, the expression...
Main Authors: | Yosuke Furuya, Yoshitaka Sekine, Haruo Kato, Yoshiyuki Miyazawa, Hidekazu Koike, Kazuhiro Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Prostate International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2287888215301070 |
Similar Items
-
Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
by: Lin Jianxin, et al.
Published: (2011-08-01) -
Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China
by: Xiao-Jun Ouyang, et al.
Published: (2018-01-01) -
Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
by: Juan Morote, et al.
Published: (2014-08-01) -
Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world
by: Anselm K. Gitt, et al.
Published: (2016-12-01) -
Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review
by: Pınar Kızılırmak, et al.
Published: (2020-03-01)